Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | RBP1 | P09455 | 1/20 | 0.32 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | CHKA | P35790 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3436780 | 0.91 | NPSR1 (0.33) | NPSR1RBP1KMT2AGAAMAPK1 | |
| Hydrochloric Acid SCHEMBL28233292 | 0.89 | NPSR1 (0.32) | NPSR1RBP1GAAMAPK1 | |
| SCHEMBL24837477 | 0.83 | USP2 (0.36) | NPSR1EHMT2 | |
| SCHEMBL20007916 | 0.81 | KMT2A (0.33) | NPSR1KMT2AGAA | |
| SCHEMBL17888369 | 0.78 | NPSR1 (0.31) | NPSR1 | |
| SCHEMBL17888395 | 0.78 | SMN1; SMN2 (0.40) | NPSR1KMT2A | |
| SCHEMBL16564680 | 0.77 | — | — | |
| SCHEMBL3478088 | 0.75 | KDM4E (0.41) | RBP1KMT2AGAA | |
| SCHEMBL17888210 | 0.75 | KMT2A (0.37) | KMT2A | |
| SCHEMBL19063296 | 0.74 | EPHX1 (0.34) | NPSR1EHMT2KMT2ACHKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023196720-A2 | LRRK2 INHIBITORS | Brenig Therapeutics, Inc. (US) | 2023-10-12 | — | — | WO | disclosed |
| WO-2022261210-A1 | KRAS MODULATORS AND USES THEREOF | QUANTA THERAPEUTICS, INC. (US) | 2022-12-15 | — | — | WO | disclosed |
| WO-2022256459-A1 | KRAS MODULATORS AND USES THEREOF | QUANTA THERAPEUTICS, INC. (US) | 2022-12-08 | — | — | WO | disclosed |